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In Brief
Compared with resistance mechanisms
that reduce pathogen burden, pathways
that regulate tolerance to damage caused
by infections are ill defined. Maurer et al.
demonstrate that autophagy, a pathway
previously shown to mediate resistance
to a variety of pathogens, confers
tolerance to Staphylococcus aureus by
limiting damage caused by bacterially
secreted a-toxin.
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Resistance and tolerance are two defense strate-
gies employed by the host against microbial
threats. Autophagy-mediated degradation of bacte-
ria has been extensively described as a major
resistance mechanism. Here we find that the
dominant function of autophagy proteins during
infections with the epidemic community-associ-
ated methicillin-resistant Staphylococcus aureus
USA300 is to mediate tolerance rather than resis-
tance. Atg16L1 hypomorphic mice (Atg16L1HM),
which have reduced autophagy, were highly sus-
ceptible to lethality in both sepsis and pneumonia
models of USA300 infection. Autophagy confers
protection by limiting the damage caused by
a-toxin, particularly to endothelial cells. Remark-
ably, Atg16L1HM mice display enhanced survival
rather than susceptibility upon infection with
a-toxin-deficient S. aureus. These results identify
an essential role for autophagy in tolerance to
Staphylococcal disease and highlight how a single
virulence factor encoded by a pathogen can deter-
mine whether a given host factor promotes toler-
ance or resistance.
INTRODUCTION
Host organisms can employ mechanisms of resistance or toler-
ance to defend against microbial threats (Medzhitov et al.,
2012; Ra˚berg et al., 2009; Schneider and Ayres, 2008). Resis-
tance mechanisms lead to destruction of the microbial agent
or reduction of its replicative capacity and include numerous
well-described cell-autonomous and multicellular immune pro-
cesses. In contrast, tolerance confers protection to the host by
minimizing damage caused by the infection without affecting
pathogen burden. Therapeutic strategies that enhance toler-
ance could replace or complement traditional means of pro-
phylaxis such as antibiotics that inevitably select for resistant
microorganisms (Ra˚berg et al., 2009; Schneider and Ayres,
2008). Mouse models of cerebral malaria and sepsis followingCellintestinal damage have demonstrated that tolerance can be
improved independently of pathogen burden by directly or
indirectly blocking CD8+ T cell migration and cytokine produc-
tion through the inflammasome, respectively (Ayres et al., 2012;
Pamplona et al., 2007). However, these examples illustrate how
tolerance mechanisms are context-specific because these
immune effectors mediate resistance in other situations.
Therefore, pathways that were previously considered to func-
tion primarily through resistance should be revisited and exam-
ined for their potential role in tolerance to clinically relevant
pathogens.
Staphylococcus aureus infection is associated with a variety
of diseases ranging from skin and soft tissue infection to
lethal sepsis and nosocomial pneumonia. The spread of
highly virulent and antibiotic-resistant strains, such as methi-
cillin-resistant S. aureus (MRSA), threatens to overwhelm the
healthcare infrastructure, and as such, this bacterium has
become one of the most important pathogens worldwide
(Klevens et al., 2007). Many strains are also resistant to other
therapeutic options currently available for patients, and
newer treatments are often associated with adverse effects
(Rodvold and McConeghy, 2014; Stryjewski and Corey,
2014). Understanding the relative contribution of tolerance
versus resistance mechanisms during Staphylococcal disease
could facilitate the development of novel therapeutic strategies
and predict whether resistant bacteria will emerge in response
to the treatment. Animal models have demonstrated that the
battery of toxins produced by S. aureus, which can vary among
different strains, accounts for much of the morbidity and mor-
tality associated with infection (Alonzo and Torres, 2014; Ber-
ube and Bubeck Wardenburg, 2013; Bubeck Wardenburg
et al., 2007a). Preventing tissue damage by neutralizing these
toxins is a promising approach to ameliorate the impact of
S. aureus infection (Alonzo and Torres, 2014; Berube and Bu-
beck Wardenburg, 2013; Bubeck Wardenburg et al., 2007a;
Kennedy et al., 2010; Sampedro et al., 2014; Vandenesch
et al., 2012).
Autophagy is a conserved cellular pathway by which cyto-
solic material is engulfed in a double-membrane vesicle,
termed the autophagosome, and targeted to the lysosome
for degradation and recycling (Levine and Kroemer, 2008).
Autophagy has been extensively demonstrated to confer
resistance to numerous bacterial pathogens through a variety
of innate and adaptive immune mechanisms, most notablyHost & Microbe 17, 429–440, April 8, 2015 ª2015 Elsevier Inc. 429
Figure 1. Autophagy Deficiency Results in
Susceptibility to Systemic S. aureus Infec-
tion in a Strain-Specific Manner
(A) Survival curve of wild-type control (WT) and
Atg16L1 hypomorph (HM) mice infected i.v. with
107 colony-forming units (CFU) USA300. n = 12–14
mice/group.
(B) Survival curve of WT and LC3B/ mice in-
fected with 107 CFU USA300. n = 20–25 mice/
group.
(C) Survival curve of WT and Atg16L1HM mice in-
fected with 107 CFU USA500. n = 10 mice/group.
(D) Survival curve of WT and Atg16L1HM mice in-
fected with 107 CFU USA400. n = 15 mice/group.
Data represent at least two independent repeats.
*p < 0.05, **p < 0.01.the direct destruction of internalized bacteria residing in the
cytosol or damaged vesicles (Gomes and Dikic, 2014). How-
ever, we previously demonstrated that autophagy-deficient
mice display an unexpected enhanced innate immune
response that increases resistance to the intestinal pathogen
Citrobacter rodentium (Marchiando et al., 2013), suggesting
that the role of autophagy during bacterial infections is more
complex in vivo, where multiple cell types and bacterial extra-
cellular life cycles are involved. Additionally, autophagy could
be contributing to tolerance mechanisms. Induction of auto-
phagy has been shown to reduce lethality primarily through
limiting damage following neuronal Sindbis virus infection and
polymicrobial sepsis (Figueiredo et al., 2013; Orvedahl et al.,
2010). These findings are consistent with the evolutionarily
conserved cytoprotective function of autophagy and necessi-
tate careful examination of this pathway in models of bacterial
infection.
To investigate the role of autophagy at the whole-organism
level, we previously generated mice in which Atg16L1 expres-
sion is disrupted by the insertion of a gene-trap mutagenesis
cassette (Cadwell et al., 2008). Atg16L1 is part of a protein com-
plex that catalyzes the conjugation of phosphatidyl-ethanol-
amine to LC3, a necessary step in autophagosome formation;
consequently, these Atg16L1 hypomorph (Atg16L1HM) mice
display reduced autophagy in all tissues examined (Cadwell
et al., 2008; He et al., 2013; Hubbard-Lucey et al., 2014; Ju
et al., 2009; Wang et al., 2012). Because these mice do not
display obvious developmental abnormalities, they provide an
opportunity to examine the function of autophagy during infec-
tious disease without prior knowledge of the cell types involved.
Here, we demonstrate that Atg16L1HM mice display increased
lethality during epidemic community-associated methicillin-
resistant Staphylococcus aureus USA300 blood and lung infec-
tion. Rather than reducing bacterial burden, we find that
autophagy confers protection from a-toxin by limiting damage
to endothelial cells. Remarkably, Atg16L1HM mice display430 Cell Host & Microbe 17, 429–440, April 8, 2015 ª2015 Elsevier Inc.enhanced survival rather than susceptibil-
ity upon infection with a-toxin-deficient
USA300, demonstrating that the role of
autophagy is dependent on the expres-
sion of a single virulence factor. When
taken together, these results identifyautophagy-mediated protection from toxinosis as a key toler-
ance mechanism during S. aureus infection.
RESULTS
Autophagy Deficiency Results in Susceptibility to
SystemicS. aureus Infection in a Strain-SpecificManner
To investigate the role of autophagy during S. aureus bacter-
emia, Atg16L1HM and wild-type (WT) control mice were intrave-
nously (i.v.) infected with three different MRSA strains: USA300
(strain LAC), USA500 (strain 2395), and USA400 (strain MW2).
Atg16L1HM mice displayed increased or accelerated lethality
when infected with USA300 and USA500, but showed similar
survival when infected with USA400 (Figures 1A, 1C, and 1D).
LC3B/ mice are missing one of several paralogs of LC3, and
therefore display a partial reduction in autophagy (Cann et al.,
2008). We found that LC3B/ mice also displayed enhanced
lethality following i.v. infection with USA300 (Figure 1B). Thus,
two distinct autophagy-deficient mouse lines are susceptible
to this common MRSA strain that accounts for significant
morbidity and mortality in humans (Gonzalez et al., 2006;
Nimmo, 2012).
The increased lethality during USA300 infection observed in
autophagy-deficient mice was unexpected based on the
in vitro studies demonstrating that S. aureus subverts the auto-
phagy pathway for intracellular survival (Mestre and Colombo,
2012; Mestre et al., 2010; Schnaith et al., 2007). To determine
whether autophagy confers protection by promoting bacterial
clearance, we quantified bacterial burden following USA300
infection of WT and Atg16L1HM using the same conditions
described above. Given that autophagy deficiency could alter
bacterial burden in a site-specific manner, we harvested blood,
spleen, kidney, lungs, heart, liver, small intestine, cecal contents,
colon, lymph nodes, and bladder. To ensure that we did not miss
a transient difference in bacterial burden, tissue samples were
harvested at a time point directly before the onset of lethality
Figure 2. WT and Atg16L1HM Mice Display
Similar Bacterial Burden during S. aureus
Infection
(A–K) Bacterial burden was quantified in blood (A),
heart (B), kidneys (C), lungs (D), spleen (E), liver (F),
small intestine (G), cecal contents (H), colon (I),
mesenteric lymph nodes (MLN) (J), and bladder (K)
harvested from WT and Atg16L1HM mice injected
i.v. with 107 CFU USA300 on days 3, 4, and 7 post
infection. Data points represent bacterial burden
in individual mice, bars represent median, and
dashed line represents limit of detection. n = 8–13
mice/condition. No significant differences in bac-
terial burden were noted when comparing the
same organ from WT and Atg16L1HM mice, except
when comparing cecal contents on day 7 (H).
Statistical analyses were performed by ANOVA
with the Kruskal-Wallis test and Dunn’s correction.
Each time point represents data pooled from 2–3
independent repeats.(day 3), a second time point when the first Atg16L1HM mice die
(day 4), and a third time point that examines surviving mice
(day 7). We did not detect a significant difference in bacterial
burdenwhen comparingWT and Atg16L1HMmice in any of these
33 conditions analyzed except a decrease in the intestinal con-
tents of Atg16L1HMmice on day 7 (Figures 2A–2K). These results
indicate that the enhanced lethality displayed by Atg16L1HM
mice is not associated with an increase in bacterial burden.
Next, we infected murine embryonic fibroblasts (MEFs) and
peritoneal macrophages derived from WT and Atg16L1HM mice
with USA300 in vitro. Atg16L1 deficiency did not alter the amount
of intracellular bacteria recovered from either cell type at any of
the infectious doses or time points analyzed (Figures S1A–S1G).
A previous study showed that Atg5/ MEFs had decreased
intracellular bacterial burden during infection with USA400
(Schnaith et al., 2007). However, we did not detect a difference
in intracellular bacteria when we compared WT and Atg16L1HM
MEFs infected with USA400 (Figure S1H), potentially due to par-
tial autophagy activity in these cells (Cadwell et al., 2008). Thus,Cell Host & Microbe 17, 429our findings suggest that Atg16L1 pro-
vides protection against USA300 through
a mechanism that does not involve
reducing bacterial burden through degra-
dation of internalized bacteria, consistent
with the in vivo quantification of bacteria.
Autophagy Mediates Susceptibility
to S. aureus Lung Infection
In addition to sepsis following blood infec-
tions, lung infection by USA300 has
rapidly emerged as a significant cause of
nosocomial pneumonia (Hageman et al.,
2006; Pasquale et al., 2013). Thus, we uti-
lized a previously described mousemodel
of pneumonia (Bubeck Wardenburg et al.,
2007a) to determine whether autophagy
deficiency increased susceptibility to
lung infection. Following intranasal inocu-
lation with USA300, Atg16L1HM micedisplayed increased morbidity and mortality compared with
WT animals (Figures 3A and 3B). The degree of histopathology
in the lung was also more severe in Atg16L1HM mice, which
was characterized by signs of vascular damage such as thrombi
in vessels, edema, and loss of integrity in the tissue architecture
(Figures 3C–3F). Disease was not due to the procedure because
all of the animals inoculated with an equal volume of PBS sur-
vived (Figure 3A). Consistent with a protective role for auto-
phagy, LC3B/ mice were also more susceptible to lethality
following intranasal infection with USA300 compared with WT
(Figure 3G).
Susceptibility to S. aureus Conferred by Autophagy
Deficiency Is Dependent on a-Toxin
S. aureus produces an incredible array of virulence factors that
display a high degree of variability in expression. Such differ-
ences between strains may explain why Atg16L1HM mice are
susceptible to i.v. injection with USA300 and USA500, but not
USA400. Many of the virulence factors encoded by S. aureus–440, April 8, 2015 ª2015 Elsevier Inc. 431
Figure 3. Autophagy Mediates Susceptibility
to S. aureus Lung Infection
(A) Survival curve of WT and Atg16L1HM mice
inoculated intranasally with 43 108 CFU USA300 or
equivalent volume of PBS. n = 15 mice/group for
USA300 and n = 5 mice/group for PBS.
(B) Disease score of WT and Atg16L1HM mice 6 hr
post intranasal inoculation with 4 3 108 CFU
USA300. Disease score was calculated using a
7-point activity assessment score based on
mobility, food and water intake, posture, and fur
ruffling (see Supplemental Experimental Pro-
cedures). n = 10 mice/group. Data represent mean
and SEM.
(C) Representative H&E-stained sections of lungs
from WT and Atg16L1HM mice 6 hr post intranasal
inoculation with 4 3 108 CFU USA300. Scale bar,
200 mm.
(D and E) Higher magnification images showing
features only present in the lungs from Atg16L1HM
mice. Black arrow head in (D) indicates fibrin
thrombus, and asterisk in (E) indicates edema. Scale
bar, 200 mm (D) or 20 mm (E).
(F) Blind quantification of pathology observed in
lungs from WT and Atg16L1HM mice. Score was
calculated using a 5-point score based on tissue
destruction, hemorrhage, and visible cocci (see
Supplemental Experimental Procedures). n = 10
mice/group. Data represent mean and SEM.
(G) Survival curve of WT and LC3B/ mice inocu-
lated intranasally with 43 108 CFU USA300. n = 15–
20 mice/group.
Data represent at least two independent experi-
ments. *p < 0.05, ****p < 0.0001.are regulated by a quorum-sensing two-component system
known as the accessory gene regulator, encoded by the agr
locus (Novick and Geisinger, 2008). We therefore infected
Atg16L1HM and WT mice with an isogenic strain of USA300 in
which the agr locus is deleted (USA300 Dagr), resulting in
decreased production of many bacterial virulence factors. Using
the same 1 3 107 colony-forming unit (CFU) dose as in previous
experiments, USA300 Dagr was unable to induce mortality in
either WT or Atg16L1HM mice following i.v. injection (Figure 4A).
Although these results suggest that agr is necessary for the
increased susceptibility observed in autophagy-deficient mice,
it is possible that a higher infectious dose is necessary to
observe a role for Atg16L1. However, we were still unable to
detect a role for Atg16L1 when mice were infected with a 10-432 Cell Host & Microbe 17, 429–440, April 8, 2015 ª2015 Elsevier Inc.fold higher dose of 108 CFU USA300
Dagr, as bothWT and Atg16L1HMmice dis-
played similar lethality (Figure 4A). These
results raise the possibility that an agr-
regulated virulence factor is involved in
the increased susceptibility observed in
autophagy-deficient mice.
Among the virulence factors regulated
by agr, the membrane-perforating toxin
a-toxin has been implicated in bacteremia
and pneumonia (Berube and Bubeck
Wardenburg, 2013). While USA300 andUSA500 produce high amounts of a-toxin, USA400 secretes
very low amounts of this toxin (Figure 4B). Thus, we next exam-
ined the role of a-toxin by infecting mice with an isogenic
USA300 mutant that contains a deletion in the gene encoding
a-toxin, hla (USA300 Dhla). Remarkably, Atg16L1HM mice in-
fected i.v. with USA300 Dhla displayed a survival advantage
compared to WT mice rather than susceptibility, especially at
the higher dose (Figures 4C and 4D). Furthermore, a reduced
amount of bacteria was recovered from intestinal tissue of
Atg16L1HM animals on day 3 post infection (Figures S2A–S2K),
suggesting that enhanced survival during infection with
USA300 Dhla could be due to increased resistance to infection.
When inoculated intranasally with 108 CFU of USA300 Dhla,
neither WT nor Atg16L1HM mice displayed lethality (Figure 4E).
Figure 4. Susceptibility to S. aureus
Conferred by Autophagy Deficiency Is
Dependent on Bacterial a-Toxin Production
(A) WT and Atg16L1HM mice were injected i.v. with
107 or 108 CFU USA300 Dagr. n = 10 mice/group.
Data represent two independent experiments.
(B) Western blot analysis of USA300, USA300 Dhla,
USA400, and USA500 using an anti-a-toxin anti-
body. MW indicates molecular weight protein
marker, WT indicates isogenic wild-type USA300,
asterisk indicates a non-specific, anti-a-toxin
cross-reactive band.
(C) WT and Atg16L1HM mice were infected i.v. with
107 CFU USA300 or USA300 Dhla. n = 7–15 mice/
group. Data represent two independent experi-
ments. *p < 0.05 comparing Atg16L1HM + USA300
versus Atg16L1HM + USA300 Dhla.
(D) WT and Atg16L1HM mice were infected i.v. with
108 CFU USA300 or USA300 Dhla. n = 7–15 mice/
group. Data represent four independent experi-
ments. ****p < 0.0001 comparing Atg16L1HM +
USA300 versus Atg16L1HM + USA300 Dhla and
****p < 0.0001 comparing Atg16L1HM + USA300
Dhla versus WT + USA300 Dhla.
(E) WT and Atg16L1HM mice were inoculated intra-
nasally with 108 CFU USA300 Dhla transformed
with either empty plasmid (USA300 Dhla+EV) or a
plasmid overexpressing hla (USA300 Dhla+phla).
n = 8–14 mice/group. Data represent three inde-
pendent experiments. *p < 0.05 comparing WT +
USA300 Dhla+EV with WT + USA300 Dhla+phla.
***p < 0.001 comparing Atg16L1HM + USA300
Dhla+EV with Atg16L1HM + USA300 Dhla+phla.Importantly, complementing the USA300Dhlamutant strain with
a plasmid overexpressing hla restored mortality in both WT and
Atg16L1HM animals (Figure 4E). Therefore, we conclude that
Atg16L1 deficiency mediates susceptibility to both sepsis and
pneumonia following S. aureus in a manner dependent on
a-toxin.
Atg16L1 Deletion in Endothelial Cells, but Not
Macrophages or Dendritic Cells, Contributes to
Enhanced Lethality
a-toxin contributes to lethal sepsis and pneumonia by binding A
Disintegrin and Metalloprotease 10 (Adam10) expressed on the
surface of endothelial cells, epithelial cells, and monocytes
(Becker et al., 2014; Powers et al., 2012). The vascular damage
observed by histopathology analysis in Atg16L1HM mice
following intranasal infection (Figures 3C–3F) may be indicative
of increased sensitivity of the endothelium to a-toxin. We inves-
tigated the role of Atg16L1 in endothelial cells during infection by
breeding mice expressing Cre recombinase under control of the
Tie2 promoter with mice that have a loxP-flanked Atg16L1 allele
(Atg16L1fl/fl-Tie2Cre). Successful deletion of Atg16L1 in endo-
thelial cells was confirmed by western blot (WB) analysis
(Figure S3E). We found that Atg16L1fl/fl-Tie2Cre mice wereCell Host & Microbe 17, 429significantly more susceptible to lethality
following infection by USA300 compared
with Atg16L1fl/fl control mice in both the
blood and lung infection models (Figures5A and 5B). Cre expression driven by the Tie2 promoter has
been reported to cause non-specific deletions of loxP-flanked
gene segments in hematopoietic cells. Although bone marrow
chimeras are frequently used to address this issue, we could
not employ this strategy because the process of generating chi-
meras (e.g., irradiation) altered the disease course (Figure S3A).
As an alternate approach, we analyzed the susceptibility of mice
in which Atg16L1 is deleted in key hematopoietic cell types
known to be essential for defense against S. aureus in the time
frame we have been examining.
Myeloid cells in particular may be relevant because Atg16L1
deletion in these cells leads to excess IL-1b production that me-
diates lethality in a model of intestinal injury (Saitoh et al., 2008).
Additionally, a-toxin mediates lethality following intranasal infec-
tion in part by inducing IL-1b production upon binding Adam10
onmyeloid cells (Becker et al., 2014). However, we did not detect
increased IL-1b in Atg16L1HM mice infected i.v. or intranasally
with USA300 compared to similarly treated WT mice (Figures
S3B–S3D). To further investigate the role of Atg16L1 in various
leukocyte populations, we utilized mice in which Atg16L1 is
deleted in myeloid cells (monocytes, macrophages, and neutro-
phils) or dendritic cells by breeding Atg16l1fl/fl mice with mice ex-
pressing the Cre recombinase under control of the lysozyme M–440, April 8, 2015 ª2015 Elsevier Inc. 433
Figure 5. Atg16L1 Deletion in Endothelial
Cells Confers Susceptibility to S. aureus-
Mediated Lethality
(A) Survival curve of Atg16L1fl/fl (controls) and
Atg16L1fl/fl-Tie2Cre mice infected i.v. with 107 CFU
USA300. n = 5–6 mice/group.
(B) Survival curve of Atg16L1fl/fl and Atg16L1fl/fl-
Tie2Cre mice inoculated intranasally with 4 3 108
CFUUSA300. n = 24mice for Atg16L1fl/fl and n = 15
mice for Atg16L1fl/fl -Tie2Cre.
(C) Survival curve of Atg16L1HM, Atg16L1fl/fl,
Atg16L1fl/fl-LyzCre, and Atg16L1fl/fl-CD11cCre
mice infected i.v. with 107 CFU USA300. n = 10
mice for Atg16L1HM, n = 21 mice for Atg16L1fl/fl,
n = 18 mice for Atg16L1fl/fl-LyzCre, n = 9 mice for
Atg16L1fl/fl-CD11cCre.
Data represent at least two independent experi-
ments. *p < 0.05.promoter (Atg16L1fl/fl-LyzCre mice) or CD11c promoter
(Atg16L1fl/fl-CD11cCre mice), respectively (Hubbard-Lucey
et al., 2014; Marchiando et al., 2013). Neither Atg16L1fl/fl-LyzCre
nor Atg16L1fl/fl-CD11cCremice displayed a difference in survival
compared to Atg16L1fl/fl controls, while Atg16L1HM mice
included in this experiment as a positive control displayed
increased lethality (Figure 5C). Thus, Atg16L1 deletion inmyeloid
and dendritic cells is not sufficient to mediate enhanced lethality.
Intranasal a-Toxin Treatment Is Sufficient to Induce
Increased Lethality in Autophagy-Deficient Mice
Wenext investigatedwhether a-toxin alone, independent of bac-
terial replication, is sufficient to induce increased lethality in
autophagy-deficient mice. To isolate biologically active toxin,
a-toxin was over-produced in an engineered strain of S. aureus
deficient in production of key cytotoxins (Newman Dhla/hlg/
lukAB/lukED;pvl) (Reyes-Robles et al., 2013). We confirmed
the presence of a-toxin in the filter-sterilized supernatant of the
toxin-overexpressing strain, but not in supernatant from the
parental toxin-deficient strain that was prepared the same way
(Figure S4A). Atg16L1HM mice inoculated via the intranasal route
with the a-toxin suspension described above were significantly
more susceptible to lethality compared with WT animals (Fig-
ure 6A). This lethality was attributable to a-toxin because neither
WT nor Atg16L1HM mice displayed lethality following inoculation
with the toxin-deficient supernatant (Figure 6A). The increased
lethality of Atg16L1HM mice inoculated with a-toxin was associ-
ated with increased protein in the bronchoalveolar lavage fluid,
suggesting that autophagy protects against disruption of endo-
thelial and epithelial barriers (Figures 6B and S4B). Because
these results were obtained in the absence of intact bacteria,
the protection conferred by autophagy cannot be through
resistance.
In addition to direct cell lysis, a-toxin induces barrier disruption
by promoting Adam10-induced cleavage of integrins E-cadherin
and VE-cadherin on epithelial and endothelial cells, respectively434 Cell Host & Microbe 17, 429–440, April 8, 2015 ª2015 Elsevier Inc.(Inoshima et al., 2011; Powers et al.,
2012). We analyzed E-cadherin cleavage
because we were unable to detect suffi-
cient amounts of VE-cadherin in lung tis-sue by WB to be able to examine cleavage. Consistent with
the increased barrier dysfunction, Atg16L1HM mice had signifi-
cantly higher levels of cleaved E-cadherin in the lungs, while total
full-length E-cadherin was similar to WT (Figures S4C–S4F).
Additionally, we detected an increase in the number of TUNEL+
cells in lung sections prepared from Atg16L1HM mice treated
with a-toxin, indicative of increased cell death in autophagy-defi-
cient conditions (Figure 6C). To identify the cells targeted by
a-toxin, single-cell suspensions of lung harvested from
Atg16L1HM and WT mice were labeled with propidium iodide
(PI) following intranasal intoxication and analyzed by flow cytom-
etry. A higher percentage of ICAM+PECAM+ endothelial cells
and EpCAM+ epithelial cells from Atg16L1HM mice incorporated
PI compared with WT (Figures 6D–6H). By comparison, only a
small percentage of the CD45+ cells, representing the hemato-
poietic compartment, incorporated PI in either Atg16L1HM or
WT mice (Figure 6F). There was no difference in cell death be-
tween WT and Atg16L1HM mice treated with toxin-deficient con-
trol supernatant (Figures 6G and 6H). These results indicate that
autophagy-deficient epithelial and endothelial cells, but not he-
matopoietic cells, are more susceptible to a-toxin during intra-
nasal intoxication.
Autophagy-Deficient Endothelial Cells Are More
Susceptible to a-Toxin In Vitro
To directly test whether autophagy protects endothelial cells
from a-toxin in vitro, primary endothelial cells were harvested
from WT and Atg16L1HM mice and maintained in culture (Fig-
ure S5A). Cell death and pore formation measured by ethidium
bromide (EtBr) incorporation were used as markers for toxin
sensitivity. Endothelial cells from Atg16L1HM mice were signifi-
cantly more susceptible to cell death induced by a-toxin
compared toWT cells (Figure 7A). Also, Atg16L1-deficient endo-
thelial cells treated with a-toxin, but not the control supernatant,
incorporated high amounts of EtBr (Figures 7B and 7C). In
contrast, peritoneal macrophages from WT and Atg16L1HM
Figure 6. Intranasal a-Toxin Treatment Is Sufficient to Induce Increased Lethality in Atg16L1-Deficient Mice
(A) Survival curve of WT and Atg16L1HM mice inoculated intranasally with a 20 ml suspension of filter-sterilized S. aureus culture supernatant containing a-toxin
(+toxin) or lacking a-toxin (-toxin). Supernatant were prepared from the exotoxin-deficient Newman Dhla/hlg/lukAB/lukED/pvl- strain ± a-toxin overexpression.
n = 15–17 mice/group.
(B) Protein content of bronchoalveolar lavage fluid of WT and Atg16L1HM mice 3 hr post-intranasal inoculation with a-toxin as in (A). n = 12–13 mice/group. Data
points represent mean and SEM.
(C) Quantification of TUNEL+ cells per field of WT and Atg16L1HM mice 3 hr post-intranasal inoculation with a-toxin as in (A). n = 3 mice/group. Data points
represent mean and SEM.
(D–H) Flow cytometry analysis of single-cell lung homogenates from WT and Atg16L1HM mice 3 hr post-intranasal inoculation with a-toxin.
(legend continued on next page)
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mice displayed a similar degree of cell death when treated with
a-toxin (Figure S5B), consistent with our findings in vivo indi-
cating that autophagy-deficiency selectively affects endothelial
and epithelial cells rather than leukocytes.
Altered Adam10 expression could explain the increased sensi-
tivity of Atg16L1-deficient endothelial cells to a-toxin. Consistent
with this possibility, WB analyses indicated that Atg16L1HM
endothelial cells, but not hematopoietic bone marrow cells,
had a striking increase in Adam10 compared with WT cells
(Figures 7D–7F). Immunofluorescence analysis confirmed the in-
crease in Adam10 observed in Atg16L1HM endothelial cells (Fig-
ures 7G and 7H). Adam10 mRNA levels were similar in WT and
Atg16L1HM endothelial cells, indicating that the increase in
Adam10 protein was due to post-transcriptional regulation
(Figure 7I).
To further implicate autophagy in the regulation of Adam10,
primary endothelial cells from WT mice were analyzed for
Adam10 protein levels under autophagy-inducing or -inhibiting
conditions. Inhibition of late-stage autophagy with ammonium
chloride (NH4Cl) or Lys05, a hydroxychloroquine derivative
(McAfee et al., 2012), resulted in increased levels of Adam10
(Figures 7J–7M). Conversely, serum starvation, a classic stim-
ulus of autophagy, decreased Adam10 levels (Figures 7N and
7O). Similarly, treatment with epirubicin, an anthracycline drug
that induces autophagy (Figueiredo et al., 2013), also led to a
decrease in Adam10 protein (Figures 7P and 7Q). Epirubicin
has been shown to protect against sepsis by inducing autophagy
in the lung (Figueiredo et al., 2013). Thus, we next tested whether
chemically inducing autophagy with epirubicin can protect
against toxinosis. Remarkably, we found that epirubicin
increased survival of WT animals inoculated intranasally with
a-toxin (Figure 7R). When taken together, these results are
consistent with a model in which autophagy inhibition in endo-
thelial cells confers susceptibility to a-toxin, which is associated
with altered Adam10 protein levels.
DISCUSSION
Despite the growing evidence that tolerance mechanisms are
critical for host defense, specific pathways that mediate
tolerance toward antibiotic-resistant bacteria have not been
sufficiently examined. We show that disruption of the auto-
phagy gene Atg16L1, and consequently autophagy, increases
S. aureus-mediated lethality in a strain-dependent manner. Dur-
ing systemic and intranasal infections, this increase in lethality
was not accompanied by a change in bacterial burden, suggest-
ing that Atg16L1 deficiency impairs tolerance rather than resis-
tance. Impaired tolerance in Atg16L1-deficient animals was
dependent on a single virulence factor secreted by S. aureus,
a-toxin. Remarkably, deletion of a-toxin in S. aureus resulted in
reversal of susceptibility between WT and Atg16L1 mutant ani-(D) Plots showing gating strategy to identify ICAM+PE-CAM+ cells within the CD4
(E) Representative plots of PI+ cells gated on the CD45ICAM+PE-CAM+ fraction a
control suspension (top panels). Samples harvested from WT and Atg16L1HM m
(F–H) Quantification of the proportion of (F) CD45+, (G) CD45EpCam+, and (H)
a-toxin or control suspension. Values are expressed as fold change over WT mic
Individual points in (B), (C), (F), (G), and (H) represent cells from individual animals
experiments. *p < 0.05, **p < 0.01, ***p < 0.001.
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ciency may actually be beneficial to the host. This observation
is reminiscent of our previous finding demonstrating that
Atg16L1 deficiency confers protection during C. rodentium
infection by reducing bacterial burden (Marchiando et al.,
2013). This reversal in susceptibility highlights the context-spe-
cific role of autophagy and underscores the contribution of path-
ogen-encoded factors in determining the outcome of inhibiting a
host defense pathway.
Pathways that maintain cell homeostasis in response to inter-
nal and external stressors promote tolerance in response to in-
fectious challenges in a variety of model organisms (Bessede
et al., 2014; Ferreira et al., 2011; Richardson et al., 2010; Taille-
bourg et al., 2014). Thus, autophagy could contribute to
tolerance as a major homeostatic pathway. Indeed, the tran-
scriptional regulator of autophagy HLH-30 (TFEB in mammals)
promotes survival in C. elegans infected with S. aureus without
affecting bacterial burden (Visvikis et al., 2014). However, the
mechanism by which HLH-30 is providing protection is unclear.
Although tolerance is frequently enhanced by dampening inflam-
mation, HLH-30 was shown to induce inflammatory cytokine
expression. How does autophagy, a cellular pathway that typi-
cally enhances immune responses, promote tolerance instead
of resistance? Rather than directly controlling cytokine expres-
sion, our results suggest that autophagy can protect cells that
are vulnerable to damage caused by a pathogen-specific viru-
lence mechanism. Atg16L1 deletion in endothelial cells, but not
myeloid or dendritic cells, recapitulated the enhanced lethality
observed in Atg16L1HM mice. Also, a-toxin promoted cell death
preferentially in Atg16L1-deficient endothelial or epithelial cells
from Atg16L1HM mice in vitro and in vivo. Thus, although auto-
phagy in other cell types may also be important during
S. aureus infection, cells that maintain barrier function appear
to be particularly sensitive to Atg16L1 deficiency in the presence
of an a-toxin-producing strain. This increased susceptibility is
consistent with increased levels of the toxin receptor Adam10
in Atg16L1-deficient endothelial cells. The finding that Atg16L1
deficiency increases Adam10 protein rather than transcript
may be related to the protein turnover function of autophagy
because we found that lysosomal inhibition leads to a similar
accumulation of Adam10. Given the broad role of autophagy in
remodeling the proteome (Mathew et al., 2014), it will be impor-
tant to determine whether additional substrates of autophagy
impact tolerance in a pathogen-specific manner.
Finally, a rigorous comparison of inbred mouse strains during
cerebral malaria indicates that subtle differences in genetic sus-
ceptibility can favor tolerance at the cost of resistance, or vice
versa (Ra˚berg et al., 2007). Our finding that Atg16L1 deficiency
reduces bacterial burden in the intestine, which is supported
by our previous finding in the C. rodentium model, suggests
that Atg16L1 can favor tolerance at the cost of resistance in5 fraction. Representative WT mouse shown.
s in (D) from lungs harvested frommice treated with a-toxin (bottom panels) or
ice are represented in the left and right panels, respectively.
CD45ICAM+PE-CAM+ cells that are PI+ 3 hr post-intranasal inoculation with
e treated with control suspension. n = 4–7 mice/group
, and bar graphs in (B) represent mean and SEM from at least two independent
c.
Figure 7. Autophagy-Deficient Endothelial Cells Are More Susceptible to a-Toxin In Vitro
(A) Percent cell death measured by the lactate dehydrogenase (LDH) assay in cultured endothelial cells harvested fromWT and Atg16L1HM mice inoculated with
a-toxin or control suspension. Data represent five independent experiments, each using cells pooled from 2 WT or Atg16L1HM mice. Data represent mean
and SEM.
(B) Representative images of ethidium bromide incorporation by endothelial cells from WT and Atg16L1HM mice inoculated with a-toxin as an assay for pore
formation. Scale bar, 10 mm.
(C) Quantification of mean fluorescent intensity (MFI) per cell from (B). n = 44 cells from 3 WT mice and 83 cells from 3 Atg16L1HM mice. Data represent mean
and SEM.
(legend continued on next page)
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certain conditions. Thus, preventing tissue damage caused by
S. aureus (e.g., through Adam10 blockade; Inoshima et al.,
2011) may not necessarily select for resistant bacteria. Addition-
ally, a threonine to alanine substitution (T300A) in Atg16L1 that
exists at high frequency in the human population has been
shown to destabilize the protein and increase the risk of devel-
oping inflammatory bowel disease, a disorder associated with
loss of tolerance toward commensal bacteria in the intestine
(Lassen et al., 2014). It is possible that mutations in autophagy
genes influence outcomes during S. aureus infection in humans
as well. However, our results in mice indicate that a host muta-
tion that increases susceptibility to one strain of S. aureus could
reduce susceptibility to another strain, depending on the levels
of a-toxin produced. Therefore, population genetic studies
may require concurrent analyses of genetic variation among
bacterial strains to successfully identify gene variants that
mediate susceptibility. Altogether, our results identify a remark-
ably specific relationship between the host pathway of auto-
phagy and a bacterial toxin that dictates tolerance toward one
of the most significant modern pathogens.
EXPERIMENTAL PROCEDURES
Mice
Age- and gender-matched 6- to 9-week-old mice on a C57BL/6 background
were used. Atg16L1HM, Atg16L1fl/fl-LyzCre, Atg16L1fl/fl-CD11cCre mice
were previously described (Hubbard-Lucey et al., 2014; Marchiando et al.,
2013; Ramanan et al., 2014). WT refers to C57BL/6 mice purchased from
The Jackson Laboratory and bred onsite to generate animals for experimenta-
tion. LC3B/ mice (originally from The Jackson Laboratory) backcrossed to
the C57BL/6 background were kindly provided by Skip Virgin (Washington
University School of Medicine). Atg16L1fl/fl-Tie2Cre mice were generated by
breeding Atg16L1fl/fl mice with Tie2Cre mice from The Jackson Laboratory.
Atg16L1fl/fl-LyzCre, Atg16L1fl/fl-CD11cCre, and Atg16L1fl/fl-Tie2Cre were
compared to littermate Cre-negative Atg16L1fl/fl mice as controls. All animal
studies were performed according to approved protocols by the NYU School
of Medicine Institutional Animal Care and Use Committee (IACUC).
Bacterial Strains and Infections
Strains used in this study are described in the Supplemental Experimental Pro-
cedures. To generate the USA300 Dhla mutant strain, USA300-AH1263
(USA300 ermS LAC) was transduced with phage 80a containing hla::erm.
The USA300 hla mutant strain was also transformed with the pOS1 vector
(empty vector) and the pDU1212 plasmid (Phla-hla) (O’Reilly et al., 1986). Bac-
teria were cultured overnight from a single colony in 5 ml Tryptic Soy Broth(D–F) Representative western blots for Adam10 and actin in whole-cell lysates pre
and Atg16L1HMmice. Quantification of Adam10 levels normalized to actin in endo
(G) Representative immuno-fluorescence staining of Adam10 in endothelial cells
(H) Quantification of mean fluorescent intensity (MFI) per cell from (E). n = 63 cell
and SEM.
(I) Adam10 mRNA expression in endothelial cells from WT and Atg16L1HM mice
(J and K) Representative western blot (J) and quantification (K) for Adam10 and a
ammonium chloride (NH4Cl) for 24 hr. n = 7 replicates/group from two independen
design).
(L and M) Representative western blot (L) and quantification (M) for Adam10 and
Lys05 for 24 hr. n = 6–9 replicates/group from two independent experiments.
(N and O) Representative western blot (N) and quantification (O) for Adam10 and a
(+serum) or media without serum (serum) for 6 hr to induce autophagy. n = 6–7
(P and Q) Representative western blot (P) and quantification (Q) for Adam10 and a
epirubicin for 6 hr. n = 4–5 replicates/group from two independent experiments.
(R) Survival curve of WTmice treated i.p. with epirubicin (0.6 mg/g body weight) or
sterilized S. aureus culture supernatant containing a-toxin (+toxin). n = 19–20 fro
*p < 0.05, **p < 0.01, ****p < 0.0001.
438 Cell Host & Microbe 17, 429–440, April 8, 2015 ª2015 Elsevier In(TSB) with shaking at 37C. Cultures were diluted 1:100 in TSB (5 ml for i.v.
infection, 50 ml for intranasal infection) and cultured shaking at 37C for an
additional 3 hr until optical density at 600 nm was 1.5 (109 CFU/ml). Intrave-
nous infection was performed via tail vein injection. Inoculum for intranasal
infection was prepared as described previously (Bubeck Wardenburg et al.,
2007b). Mice were anesthetized using 200 ml Avertin. 20 ml bacterial slurry
was administered via the left nare, and animals were held upright for 1 min
post inoculation then laid prone to recover. Inoculum was quantified by plating
serial dilutions on mannitol salt agar plates (MSA, BD Biosciences). For in vivo
epirubicin treatment, WT animals were injected i.p. with 0.6 mg/g body weight
epirubicin in PBS or vehicle-only control immediately prior to intranasal inoc-
ulation with a-toxin.
a-Toxin Preparation
TheNewmanDhla/hlg/lukAB/lukED;pvl strain (Reyes-Robles et al., 2013) was
transformed with the pDU1212 (Phla-hla) plasmid (O’Reilly et al., 1986). Trans-
formed bacteria (a-toxin+) and the parental strain (a-toxin control) were
cultured overnight in RPMI (GIBCO) supplemented with 1% CAS amino acids
(RPMI/CAS) diluted 1:100 and grown at 37C with shaking for an additional
6 hr. Cultures were centrifuged for 15 min at 4,000 rpm and 4C. Supernatants
were filter-sterilized (0.22 mm) and concentrated to 103 using Spin-X UF
Concentrator tubes (Corning) at 4000 rpm and 4C for 80 min. Supernatants
containing a-toxin and toxin-less control supernatants were aliquoted into
one-time-use stocks frozen at 80C.
Statistics
GraphPad Prism v6 was used for analysis. Differences between two groups
were assessed by two-tailed unpaired t test. Analyses involving multiple com-
parisons were performed by an ANOVA with the Holm-Sidak test. Bacterial
burden in tissue specimens did not display normal distribution and was
analyzed by the non-parametric Wilcoxon-Mann-Whitney test, or Kruskal-
Wallis test and Dunn’s correction for multiple comparisons on log-transformed
CFU values. Survival between groups of mice was analyzed by the log-rank
Mantel-Cox test.
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